Updates on Pyoderma Gangrenosum

In an update on pyoderma gangrenosum (PG), Dr. Alex Ortega, an interim chair of dermatology, shared key insights into recent advances in understanding and treating this rare inflammatory skin condition. PG is characterized as the most common ulcerative neutrophilic dermatosis, affecting mainly women and impacting quality of life. Dr. Ortega discussed the challenges in diagnosing PG, noting diagnostic errors can reach 20%. He highlighted the need for robust criteria for diagnosis, revealing that the Paracelsus criteria show high specificity and sensitivity in identifying PG. Treatment options remain limited, but recent trials have shown promising results for biologics and combination therapies. He emphasized the importance of managing co-morbidities and the holistic care of patients, including debridement and pain management. Dr. Ortega underscored the critical need for improved research methodologies at the international level to establish a standardized approach to studying PG. He concluded by expressing gratitude to his patients and collaborators for their contributions to advancing the field, highlighting ongoing studies and the potential for future treatment breakthroughs.